Eli Lilly in India

Eli Lilly in India

Eli Lilly in India: Rethinking the
Joint Venture Strategy

Core Competence & Competitive Advantage:
Innovation, research and drug development

Lilly’s mission is to “create and deliver superior health care solutions in order to provide customers around the world with optimal clinical and economic outcomes” (Eli Lilly). This requires that the company operate ethically, taking into account health and environmental issues in respect to its global operations as well as local impact. Additionally, Lilly’s mission and values are expressed in the company’s desire to “provide innovative medicines that enable people to live longer, healthier, and more active lives” (Eli Lilly). The firm’s core competencies relate to its ability to “discover, develop, manufacture and sell a broad line of human health and agricultural products” – in short its ability to innovate (p. 232). Lilly has five specific core competencies: “established markets, oncology, diabetes, emerging markets, and animal health” (Bajgrowicz). The company’s years of experience, commitment to scientific and managerial excellence as well as its global reach and strategic leveraging has promoted its continued success. Lilly’s competitive advantage is linked to its ability to innovate. Specifically, the integration of highly sophisticated technologies in combination with an interdisciplinary approach to research and development have “created a new model for Lilly that gives the company a competitive advantage in bringing breakthrough medicines to patients in a more efficient, productive, and dependable manner” (Eli Lilly).

Core Competence & Competitive Advantage:
Manufacturing and integrated processes
 

Ranbaxy’s mission is to “to become a Research-based International Pharmaceutical Company, committed to constantly pushing new frontiers of knowledge in pursuit of new horizons of science” (Ranbaxy). This requires visionary management and a serious, researchoriented focus for...

Similar Essays